Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03, versus $0.10 reported last year. Revenue for the quarter came in at $8.04 million, versus $9.33 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• RenaissanceRe Holdings (RNR) PT Raised to $315 at TD Cowen
• Samsung Electronics Co Ltd. (005930:KS) (SSNLF) PT Raised to KRW550,000 at BofA Securities